Dongliang Liu is a Postdoctoral Associate at the Michael E. DeBakey Department of Surgery, Baylor College of Medicine. He holds a Ph.D. from Xinjiang University. He is also a member of the Chinese Society for Immunology, the National Postdoctoral Association, the American Association for Cancer Research, and the China Zoological Society. His research interests include Cancer therapy (especially for pancreatic cancer immunotherapy), Chimeric virus-like particles (VLPs) vaccine (especially for cancer vaccines), Novel antibiotics development including antimicrobial peptides, Epitomics, and multi-epitope peptide vaccine development for pathogenic viruses.

Jianming Lu is an Assistant Professor of Surgery at the Division of Surgical Oncology, Baylor College of Medicine. He graduated from Lanzhou Medical School Affiliate Hospital and received his M.S. and Ph.D. His research is focused on several basic science and translational research projects that are highly relevant to clinical diseases and pancreatic cancer. His research interests include Nanoparticle drug delivery, Cardiovascular disease, Pancreatic Cancer, Oxidative stress, Free radicals, and Antioxidants.

Changyi Chen is a Professor of Surgery and Molecular & Cellular Biology at the Baylor College of Medicine, Houston, Texas, USA. Currently, he serves as Molecular Surgery Endowed Chair, Director of the Molecular Surgeon Research Center, and Vice Chair for Research of the Michael E DeBakey Department of Surgery. He received his medical degree from Southeast University School of Medicine, China in 1982 and practiced general surgery for 7 years in China. In 1989, he immigrated to the United States for his advanced education in the biomedical area and to develop his academic career. He received his Master of Science degree from the University of Texas at El Paso, and his Ph.D. degree from Georgia Institute of Technology. From 1996 to 2002, he was an Assistant Professor at the Department of Surgery, Emory University, Atlanta, Georgia. Since 2002, he has been recruited to the Baylor College of Medicine. He is also a member of the National Academy of Inventors (NAI). His research interests include Pancreatic cancer, Hyperuricemia, uric acid-lowering drug discoveries, LGA-PEI-based nanotechnology drug delivery systems, Pancreatic cancer, ACE2 inhibitors, drug discoveries, Endothelial dysfunction and vascular disease, Angiogenesis, Atherosclerosis, Cardiovascular disease, Endothelial nitric oxide synthase, Hemodynamics, Vascular tissue engineering, Oxidative stress, and antioxidants.

Qizhi Yao is a professor of Surgery and of Molecular Virology & Microbiology, Pathology & Immunology, and Pharmacology at Baylor College of Medicine and a health research scientist at the Center for Translational Research on inflammatory diseases at Michael E. DeBakey VA Medical Center in Houston, USA. She earned her medical degree from the Southeast University School of Medicine in China (1986) and a doctoral degree from Emory University School of Medicine in Atlanta Georgia, USA (1996). After a brief postdoctoral training in Dr. Richard Compans’ lab, she became an assistant professor in the Department of Microbiology and Immunology at Emory University School of Medicine in 1997. She was then recruited to Baylor College of Medicine as an associate professor in the Michael E. DeBakey Department of Surgery, Molecular Virology and Microbiology in 2002, and promoted to a full professor in 2007. She is a member of many professional societies including the American Society for Virology (ASV), the American Association of Immunologists (AAI), and the American Association for Cancer Research (AACR), etc. She is also a member of the Center for AIDS Research (CFAR) and the Dan L Duncan Cancer Center (DLDCC).  She is one of the pioneer researchers in developing chimeric virus-like particles for HIV mucosal vaccine and pancreatic cancer immunotherapy.